Toe Gangrene as the First Presenting Symptom of Essential Thrombocythemia: A Case Report.

ischemia lower limb myeloproliferative neoplasm thrombocythemia thrombosis

Journal

Cureus
ISSN: 2168-8184
Titre abrégé: Cureus
Pays: United States
ID NLM: 101596737

Informations de publication

Date de publication:
Jul 2023
Historique:
accepted: 24 07 2023
medline: 25 8 2023
pubmed: 25 8 2023
entrez: 25 8 2023
Statut: epublish

Résumé

Essential thrombocythemia is a myeloproliferative neoplasm. Thrombosis and bleeding complications are common with myeloproliferative neoplasms, particularly essential thrombocythemia and polycythemia vera. Here, we report the case of a 52-year-old female who presented initially with painful toe swelling and discoloration. Initial imaging showed a small abscess. An incision and drainage, and debridement of toe dry gangrene were performed twice in two months with no improvement in her complaint and worsening discoloration, ending in a toe amputation. Two years later, the patient was referred to a hematology clinic for a high platelet count. On review of her medical records, the patient had the same numbers during the initial presentation. The patient's condition was diagnosed retrogradely by a hematologist as essential thrombocythemia. This case sheds light on myeloproliferative neoplasm as a differential diagnosis in patients with atypical thrombosis. Thinking in such a way could have diagnosed our patient two years earlier.

Identifiants

pubmed: 37621813
doi: 10.7759/cureus.42388
pmc: PMC10446243
doi:

Types de publication

Case Reports

Langues

eng

Pagination

e42388

Informations de copyright

Copyright © 2023, Altayyan et al.

Déclaration de conflit d'intérêts

The authors have declared that no competing interests exist.

Références

Blood. 2013 Mar 7;121(10):1720-8
pubmed: 23315161
Semin Oncol. 2002 Jun;29(3 Suppl 10):16-21
pubmed: 12096353
Semin Thromb Hemost. 2006 Apr;32(3):171-3
pubmed: 16673273
Blood. 2015 Dec 10;126(24):2585-91
pubmed: 26486786
Technol Cancer Res Treat. 2022 Jan-Dec;21:15330338221086396
pubmed: 35341409
Gene. 2019 Mar 20;689:34-42
pubmed: 30553997
Cancer. 1990 Aug 1;66(3):549-56
pubmed: 2364366
Semin Thromb Hemost. 2006 Apr;32(3):174-207
pubmed: 16673274
Semin Thromb Hemost. 1997;23(5):463-72
pubmed: 9387205
Am J Hematol. 2008 May;83(5):359-62
pubmed: 18181200
N Engl J Med. 2005 Jul 7;353(1):33-45
pubmed: 16000354
Leukemia. 2008 Nov;22(11):1990-8
pubmed: 18843285
Blood. 2011 May 5;117(18):4706-15
pubmed: 21389325
Semin Thromb Hemost. 2019 Sep;45(6):604-611
pubmed: 31382304
Ther Adv Hematol. 2019 Aug 30;10:2040620719870052
pubmed: 31516686
Cancer Med. 2020 Jul;9(13):4512-4526
pubmed: 32351024

Auteurs

Mahmoud M Altayyan (MM)

Department of Medical Education, Hamad Medical Corporation, Doha, QAT.

Mohammad Abu-Tineh (M)

Department of Medical Oncology, Hematology, and Bone Marrow Transplant, National Center for Cancer Care and Research, Doha, QAT.

Awni Alshurafa (A)

Department of Medical Oncology, Hematology, and Bone Marrow Transplant, National Center for Cancer Care and Research, Doha, QAT.

Mohammed Abdulgayoom (M)

Department of Medical Oncology, Hematology, and Bone Marrow Transplant, National Center for Cancer Care and Research, Doha, QAT.

Mohammad Afana (M)

Department of Medical Oncology, Hematology, and Bone Marrow Transplant, National Center for Cancer Care and Research, Doha, QAT.

Khalid Ahmed (K)

Department of Medical Oncology, Hematology, and Bone Marrow Transplant, National Center for Cancer Care and Research, Doha, QAT.

Haneen A Toba (HA)

Department of Medical Education, Hamad Medical Corporation, Doha, QAT.

Mohamed A Yassin (MA)

Department of Medical Oncology, Hematology, and Bone Marrow Transplant, National Center for Cancer Care and Research, Doha, QAT.

Classifications MeSH